Chemoinformaics analysis of octadecyl 2-(2-octadecoxy-2-oxoethyl)sulfanylacetate
Molecular Weight | 655.127 | nRot | 38 |
Heavy Atom Molecular Weight | 576.503 | nRig | 2 |
Exact Molecular Weight | 654.562 | nRing | 0 |
Solubility: LogS | -8.106 | nHRing | 0 |
Solubility: LogP | 14.638 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 123 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 78 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 40 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 124.918 |
nHD | 0 | BPOL | 85.9181 |
QED | 0.049 |
Synth | 2.25 |
Natural Product Likeliness | -0.135 |
NR-PPAR-gamma | 0.017 |
Lipinski | Rejected |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.039 |
HIA | 0.004 |
CACO-2 | -5.521 |
MDCK | 0.00000421 |
BBB | 0.001 |
PPB | 1.0278 |
VDSS | 3.961 |
FU | 0.00638834 |
CYP1A2-inh | 0.024 |
CYP1A2-sub | 0.102 |
CYP2c19-inh | 0.105 |
CYP2c19-sub | 0.036 |
CYP2c9-inh | 0.018 |
CYP2c9-sub | 0.953 |
CYP2d6-inh | 0.034 |
CYP2d6-sub | 0.004 |
CYP3a4-inh | 0.157 |
CYP3a4-sub | 0.012 |
CL | 5.44 |
T12 | 0.029 |
hERG | 0.899 |
Ames | 0.005 |
ROA | 0.004 |
SkinSen | 0.992 |
Carcinogencity | 0.027 |
EI | 0.924 |
Respiratory | 0.552 |
NR-Aromatase | 0.057 |
Antiviral | No |
Prediction | 0.605174 |